A phase 1 multidose study of SGN-30 immunotherapy in patients with refractory or recurrent CD30+ hematologic malignancies

Nancy L. Bartlett, Anas Younes, Matthew H. Carabasi, Andres Forero, Joseph D. Rosenblatt, John P. Leonard, Steven H. Bernstein, R. Gregory Bociek, Jennie M. Lorenz, Bruce W. Hart, Jeremy Barton

Research output: Contribution to journalArticlepeer-review

145 Scopus citations

Fingerprint Dive into the research topics of 'A phase 1 multidose study of SGN-30 immunotherapy in patients with refractory or recurrent CD30<sup>+</sup> hematologic malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds